Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
$0.00
$0.00
$0.00
$6K1.6183,499 shsN/A
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
$0.50
$0.22
$8.67
$450.52M1.25464,030 shs21,870 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.52
+0.8%
$2.53
$0.82
$3.38
$90.94M1.141.76 million shs1.11 million shs
Organovo Holdings, Inc. stock logo
ONVO
Organovo
$3.94
$1.56
$21.96
$3.47M1.13617,505 shs243,634 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
0.00%0.00%0.00%0.00%+150.00%
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
0.00%0.00%0.00%0.00%0.00%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
0.00%+3.73%-3.10%+65.56%+145.10%
Organovo Holdings, Inc. stock logo
ONVO
Organovo
0.00%0.00%0.00%-8.93%-77.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
1.9987 of 5 stars
3.52.00.00.02.60.00.6
Organovo Holdings, Inc. stock logo
ONVO
Organovo
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
0.00
N/AN/AN/A
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
0.00
N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00257.14% Upside
Organovo Holdings, Inc. stock logo
ONVO
Organovo
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ONVO, MBOT, IDRA, and GNCA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 6/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
$1.91M0.00N/AN/A$0.47 per share0.00
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
N/AN/AN/A0.29$0.56 per shareN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.17 per shareN/A
Organovo Holdings, Inc. stock logo
ONVO
Organovo
$122K0.00N/AN/A$0.02 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
-$33.20M-$0.61N/AN/AN/AN/A-182.88%-62.76%N/A
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
$98.09M-$0.32N/AN/AN/AN/A-68.74%-34.26%N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$11.44M-$0.65N/AN/AN/AN/A-110.27%-94.20%8/13/2025 (Estimated)
Organovo Holdings, Inc. stock logo
ONVO
Organovo
-$14.67M-$10.20N/AN/AN/A-10,151.64%-346.26%-187.53%N/A

Latest ONVO, MBOT, IDRA, and GNCA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
N/AN/AN/AN/AN/A
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
Organovo Holdings, Inc. stock logo
ONVO
Organovo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
0.24
1.35
1.35
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
N/A
1.56
1.56
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
16.19
16.19
Organovo Holdings, Inc. stock logo
ONVO
Organovo
N/A
0.72
1.72

Institutional Ownership

CompanyInstitutional Ownership
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
0.64%
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
12.18%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
Organovo Holdings, Inc. stock logo
ONVO
Organovo
8.23%

Insider Ownership

CompanyInsider Ownership
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
1.61%
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
5.05%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
Organovo Holdings, Inc. stock logo
ONVO
Organovo
3.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Genocea Biosciences, Inc. stock logo
GNCA
Genocea Biosciences
7058.73 million57.79 millionNot Optionable
Idera Pharmaceuticals, Inc. stock logo
IDRA
Idera Pharmaceuticals
3262.36 million59.21 millionOptionable
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million34.65 millionOptionable
Organovo Holdings, Inc. stock logo
ONVO
Organovo
201.70 million14.79 millionOptionable

Recent News About These Companies

Two new option listings and one option delisting on April 24th
Organovo announces VivoSim to carry forward 3D bioprinting, legacy tech
VivoSim to Carry Forward Organovo 3D Bioprinting
Organovo expects to meet requirements for continued listing on Nasdaq
Organovo sees cash runway through the end of FY26
Organovo, Inc.: Organovo Provides Business Update
Organovo Provides Business Update
Organovo Provides Business Update
Organovo closes sale of FXR program to Eli Lilly
Organovo trading halted, news pending

New MarketBeat Followers Over Time

Media Sentiment Over Time

Genocea Biosciences stock logo

Genocea Biosciences NASDAQ:GNCA

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.

Idera Pharmaceuticals stock logo

Idera Pharmaceuticals NASDAQ:IDRA

Aceragen, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.52 +0.02 (+0.80%)
As of 04:00 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Organovo stock logo

Organovo NASDAQ:ONVO

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive 3D bioprinted human liver tissue with distinct hepatocellular and non-parenchymal cell compartments. The company was incorporated in 2007 and is headquartered in San Diego, California.